Fondaparinux is used to prevent a type of blood clot called deep vein thrombosis (DVT), which can lead to blood clots in the lungs. It is marketed by GlaxoSmithKline. Reference standards of Fondaparinux API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object ( [pname] => Fondaparinux - API Standards [catalogue_number] => PA 33 36000 [category_ids] => ,94,78,70,82,88, [chemical_name] => [weight] => 1508.22 [form] => C31H53N3O49S8 [cas] => 104993-28-4 [pslug] => 104993-28-4-fondaparinux-api-pa3336000 [latest_product] => 0 [linkproducts] => 1 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA 33 36000
CAS :
Molecular Formula : C31H53N3O49S8
Molecular Weight : 1508.22
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....